Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia?Julie Kreyenbuhl, M. Valenstein, Sohail Soliman et al.|Schizophrenia Bulletin|2008Cited by 101
Long-Term Antipsychotic Polypharmacy in the VA Health System: Patient Characteristics and Treatment PatternsJulie Kreyenbuhl, F. C. Blow, M. Valenstein et al.|Psychiatric Services|2007Cited by 29